Minimally invasive liver resection (MILR) was introduced in the 1990s and subsequently developed at a number of specialized centers, where it was shown to be both safer and more effective than open techniques.
PAST
Minimally invasive liver resection (MILR) was introduced in the 1990s and subsequently developed at a number of specialized centers, where it was shown to be both safer and more effective than open techniques. 1 These early experiences led to consensus statements supporting its use for appropriately selected patients. 2 Despite this growing acceptance of MILR, little was known about how it might translate into practice outside specialized, highvolume hepatobiliary surgery centers. With a learning curve of approximately 45-60 cases, it is reasonable to question whether MILR will maintain the same risk profile in low-volume centers. 3 This study aimed to answer this question by comparing the outcomes of MILR with those of open resection (OLR) for primary liver malignancy in a national registry not limited to specialized centers.
PRESENT
The study demonstrated that MILR has expanded beyond high-volume centers, and that patient selection criteria for MILR are similar regardless of treatment center volume. Primary factors influencing selection for MILR included older age, higher Charlson comorbidity score, smaller tumor size, and segmental resections. The study also demonstrated that both 90-day mortality and overall survival do not differ between MILR and OLR. 4 Notably, this finding was true in both high-and low-volume centers, suggesting that implementation of MILR does not have a negative impact on the quality of care at an individual treatment center. However, the findings must be cautiously interpreted in the context of an observation that 90-day mortality for all liver resections (both OLR and MILR combined) is lower in high-volume centers.
FUTURE
Within the life cycle of new surgical technologies, a significant amount of attention is focused on initial descriptions and validation of safety and efficacy. Less attention is paid to how these technologies are best implemented and their effectiveness once subjected to a heterogeneous set of practice environments. Although this study supports the safety of wider MILR dissemination, it also reinforces ongoing efforts to regionalize complex hepatobiliary surgery to centers of excellence. Although it appears that MILR can be safely implemented across a range of practice settings, the study data again call into question the prudence of liver resections at low-volume treatment centers. Both surgeons and hospital systems often strive to provide the most cutting-edge treatment options for patients, but the investment of effort and money to provide these technologies may sometimes be better appropriated for efforts that have the potential to improve care for all patients. Future efforts should not be focused on how MILR can be implemented in more centers, but on either how safety of liver resection can be improved in lowvolume centers or how care of patients can be effectively regionalized to high-volume centers.
